PHG · Koninklijke Philips N.V. NY Reg
$24.59
-0.04% last session
End-of-day data · close of 2026-09-11
Market cap
$24B
Enterprise value
$30B
Trailing P/E
18.5
Forward P/E
12.9
Dividend yield
4.0%
Beta
0.91
Avg volume
1M
Employees
64K
Daily Change %
-0.04%
5 Days Change
-4.98%
10 Days Change
-7.48%
30 Days Change
-8.21%
60 Days Change
-10.02%
Month to Day Change
-7.48%
Year to Day Change
-5.62%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — PHG
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-08-03
Latest call per bank · past 12 months
UBS
Neutral$0.00
-100.0% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-03 | UBS | Downgrade | Buy → Neutral | $0.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-09-11
- RSI (14): RSI is 25 — oversold territory; selling pressure looks stretched.
- Price vs 50-day MA: Trading 7.8% below the 50-day MA ($26.66).
- Price vs 200-day MA: Trading 9.0% below the 200-day MA ($27.02).
- MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
- MACD (12,26,9): MACD histogram is negative (-0.28) — short-term momentum is fading.
- 52-week range: Price is within 10% of the 52-week low ($24.59).
PHG Price Chart
Loading chart for PHG…
Fundamentals
About Koninklijke Philips N.V. NY Reg
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
More in Medical Devices
ABT
Abbott Laboratories
$178B -16.0% YTD
MDT
Medtronic plc.
$116B -3.0% YTD
SYK
Stryker Corporation
$106B -22.8% YTD
BSX
Boston Scientific Corporation
$62B -54.8% YTD
EW
Edwards Lifesciences Corporatio
$49B 1.8% YTD
DXCM
DexCom, Inc.
$31B 27.3% YTD
GEHC
GE HealthCare Technologies Inc.
$29B -21.6% YTD
STE
STERIS plc (Ireland)
$21B -15.5% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.